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Abstract
Introduction: Trachoma is a disease that can lead to visual impairment and ultimately blindness. Previous estimates of
health losses from trachoma using the Global Burden of Disease methodology have not, however, included the stage prior
to visual impairment. We estimated the burden of all stages of trachoma in South Sudan and assessed the uncertainty
associated with the severity and duration of stages of trachoma prior to full blindness.
Methods: The prevalence of trachoma with normal vision, low vision and blindness in the Republic of South Sudan has been
estimated previously. These estimates were used to model the incidence and duration of the different stages employing
DISMOD II. Different assumptions about disability weights and duration were used to estimate the Years Lived with
Disability (YLD).
Results: We have estimated the total burden of trachoma in South Sudan to be between 136,562 and 163,695 YLD and
trichiasis with normal vision contributes between 5% and 21% of the total depending on the disability weight applied.
Women experience more of this burden than men. The sensitivity of the results to different assumptions about the disability
weights is partly dependent upon the assumed duration of the different disease states.
Interpretation: A better understanding of the natural history of trachoma is critical for a more accurate burden estimate.
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Introduction
Trachoma is a neglected tropical disease that is endemic in the
Republic of South Sudan and more than 50 other countries in the
world [1]. Globally, trachoma is the leading infectious cause of
blindness and the eighth most common blinding disease [2].
When susceptible individuals come into contact with the
bacterium Chlamydia trachomatis, they may become infected.
Recurrent re-infection by the bacterium can eventually lead to
the repositioning of the eyelashes back towards the cornea, a
condition known as trichiasis. Without treatment this state
eventually begins to impair the individual’s vision and ultimately
leads to blindness.
Many neglected tropical diseases cause years of suffering. When
the Global Burden of Disease methodology is used to assess the
public health importance of chronic conditions such as trachoma,
the resulting Disability Adjusted Life Years (DALYs) estimates are
dominated by the estimated years lived with disability (YLD). The
burden estimates will thus be sensitive to the disability weights
applied to different health states. While this is an issue for all
nonfatal conditions, it can be a particularly important issue for
conditions that are highly prevalent with lower levels of severity
[3]. This is because small absolute changes to the already small
disability weights can make proportionately large differences to the
overall estimate. Uncertainty about disability weights may
therefore be most consequential where chronic, low severity
conditions exist in large parts of the populations. This describes the
case of trachoma in South Sudan.
Previous assessments of the global burden of trachoma have not
included health losses from stages prior to visual impairment. Prior
to the loss of visual acuity, however, trichiasis is associated with
pain, photophobia and sensitivity to smoke and dust and therefore
reduced capabilities in everyday life [4]. Frick et al [5], for
example posited that trichiasis with normal vision may result in
economic burden comparable to trachomatous low vision and one
study has suggested that the inclusion of trichiasis with normal
vision in the burden estimate could add up to 50% to the total
burden of trachoma [6].
Between 2001 and 2005 Ngondi et al [7] collected data on
visual acuity in the Mankien district providing the most reliable
estimates of the prevalence of trichiasis with normal vision, low
vision and blinding available for South Sudan. According to these
observations and extrapolating to the whole of South Sudan, it is
clear that many of those with trichiasis are not visually impaired
and have thus not been included in the attempts to estimate the
burden of trachoma.
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the least severe end of the disease spectrum is likely to make a
material difference to the estimate of disease burden. A secondary
aim is to employ assumptions derived from previous studies and
empirical sources to assess the sensitivity of the YLD estimates of
trichiasis with low vision and trichiasis with normal vision to
uncertainty in the natural history model in terms of both the
duration of different states of trichiasis and their disability weights.
Methods
National prevalence estimates
The detailed methods for the population based trachoma
prevalence surveys have been described elsewhere [7]. In brief,
surveys were conducted in ten districts in South Sudan between
September 2001 and May 2005. Using a two-stage cluster random
sample survey design a total of 23, 139 people were examined for
trachoma signs using the WHO simplified grading system [8].
Visual acuity testing was conducted in Makiem payam district
to assess distribution of vision status in people presenting with
trichiasis. Three stages of vision loss were recorded according to
the level of presenting visual acuity (Table 1). A two-stage cluster
sampling method was used to select the households for visual
acuity (VA) testing. Villages were selected in the first stage and
households in the second. A total of 3,567 present members of the
selected household were tested for VA. VA testing was conducted
using the Snellen E chart at 6 meters. Those with VA,6/60, were
evaluated with the Snellen chart at 3 meters and those with
VA,3/60 were evaluated by counting fingers, hand movement
and light perception as appropriate. An ordinal logistic regression
model to the observed VA data was used to explore the age and
sex distribution of the three categories of vision status in
participants with trichiasis: normal vision; low vision; and
blindness. All participants in whom trichiasis and cataract was
identified were excluded from analysis; however, it was not
possible to adjust for visual impairment due to other causes such as
refractive errors [9,10].
Age-grouped and sex specific prevalence of trichiasis was
estimated from the cross-sectional surveys and a logistic curve
fitted to smooth the prevalence estimates across age groups. The
prevalence of vision status in the sample population was calculated
by multiplying the predicted probability of each vision status with
the overall prevalence of trichiasis (9).
Demographic data
Abridged life tables for Sudan for the year 2001 were obtained
from the WHO Statistical Information System (WHOSIS) for
males and females separately [11]. Demographic estimates for
South Sudan are based on model life tables because vital
registration data are either poor or not available. Life tables were
collapsed to represent 5-year age groups from age zero to 75
years and above. Years Lived with Disability (YLD) estimates
were estimated using prevalence proportions in South Sudan
applied to one third of the total Sudanese population (South
Sudan made up about one third of the total population of Sudan
in 2001).
Relative risk of mortality
Like the authors of the Global Burden of Disease study in 2000,
we maintained the same assumptions here and applied relative
risks of 2.5 and 1.5 of death for blindness and low vision
respectively [12].
Remission
The disabling sequelae of an established trachoma infection do
not remit unless treated early enough. It was assumed, therefore,
that the population has no access to treatment and that there is no
remission once trichiasis has developed.
Modelling the incidence and duration of trichiasis
The public-domain disease modelling software, DisMod II
[13], was used to model trachoma in South Sudan and estimate
unavailable parameters. DisMod II is a generic mathematical
disease model which describes the relation between incidence,
prevalence and mortality (IPM model) and can be used to
supplement observational data producing internally consistent
epidemiological estimates. Here the prevalence of each of the
three stages of trichiasis in the district of Mankien, as well as
assumptions about the remission rates and relative risks of
mortality, were used to generate the estimated incidence and
duration of each stage of the condition for the population of
South Sudan.
Incidence was first calculated for blindness using the
prevalence, the assumed relative risk of mortality of 2.5 and a
remission rate of zero. While the only exit from blindness from
trachoma is death, low vision has two exits, death and blindness.
DisMod models only a single disease specific exit (case fatality)
from the prevalent state, therefore to account for these double
exits the incidence of blindness was added to the case fatality for
trichiasis with low vision. Similarly, the same logic was applied to
trichiasis with normal vision which we assumed had no excess
mortality, by setting the case fatality of trichiasis with normal
vision in the DisMod model equal to the incidence of trichiasis
with low vision.
Table 1. Definition of vision status adopted from the
international statistical classification of diseases (Source: WHO
[30]).
Condition Definition
Blindness Visual acuity of ,3/60 in the better eye
Low Vision Visual acuity of ,6/18 but $3/60 in the better eye
Normal Vision Visual acuity of $6/18 in the better eye
doi:10.1371/journal.pntd.0001538.t001
Author Summary
Trachoma is an infectious disease that is endemic to the
Republic of South Sudan. In the absence of appropriate
treatment recurrent re-infection in an individual will lead
to progressively severe states of trachoma, eventually
leading to the loss of visual acuity and finally blindness.
Here we distinguish between three separate states of
disease: trachoma with normal vision, trachoma with low
vision and trachoma with blindness. The first of these
states, trachoma with normal vision, is the least severe and
the impact of this state on a population has not been well
investigated. Trachoma, even before any loss of vision,
comes with a great deal of pain and social consequences,
and thus disability. In this study we employ data from
South Sudan and estimate the burden caused by trachoma
with normal vision for the first time. In doing so, we also
reveal the extent of the gaps in our knowledge
surrounding the natural history of trachoma and highlight
areas of research that require urgent attention.
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Years Lived with Disability (YLD) estimates were calculated
with the standard formula [14,15]. Estimates were calculated with
and without age weighting and discounting at 3%. Estimates
presented here follow conventional age-weighting and discounting
(3,1). Duration estimates for each age group and each disease stage
were obtained from the DisMod II output.
Duration
In our analysis we have used durations gained from two sources.
For the first aim of our study, to assess the additional burden of
trichiasis prior to loss of vision, we employed the durations
obtained from modelling the observed prevalence, relative
mortalities (or case fatalities) and remission rates using DisModII.
For the second aim, the assessment of different assumptions about
duration and disability weights, we have used two scenarios for
both trichiasis with normal vision and with low vision using
evidence gathered from literature.
Ghambir et al [16] reviewed all studies which reported an
estimate of trachoma disease incidence and trachoma disease
duration. Results varied greatly. In Tanzanian women, 27% of
those with trichiasis had developed corneal opacity (CO) within 10
years [17]. In The Gambia 15% of a sample with trichiasis
developed visual impairment or blindness in 12 years [18]. The
range of durations cited in the literature suggests that environ-
mental and contextual factors play an important role in the natural
progression of the disease [16].
As the largest study of its kind, the estimates of transition
observed by Muno ˜z et al [17] were used as a basis here to make
some assumptions about duration of trichiasis with normal vision.
In their study of 4,898 women in Tanzania, 10-year cumulative
incidence of CO from trichiasis was up to 35.1% in age groups
under 35 and between 42.7% and 53.5% in age groups 35 and
above. CO has not been further graded in the literature and there
is no evidence to directly suggest duration of the low vision state.
One study in The Gambia [18] found that over a 12 month period
between 5% and 17% of those with incident CO transitioned to
progressive CO.
From the above evidence we conservatively conjectured, that it
could take about ten years for 50% of those 35 and above to
transition to CO and about 20 years for those under 34 and
younger to do so. We constructed an arbitrary range of durations
positing that it may take between 15 to 25 years for 50% of those
under 35, and between 5 and 15 years for those 35 and above, to
progress from trichiasis with normal vision to trichiasis with low
vision. It was also assumed that transition from low vision to
blindness could take on average between 3 to 10 years (Table 2).
Disability weights
The burden of trichiasis with normal vision has never been
assessed before so it was necessary to derive a disability weight for
the condition. Using DWs developed for other conditions for the
GBD we have assumed the DW of trichiasis with normal vision to
be within the range of 0.024 and 0.12. The lower and upper limit
of this range are intended to represent consistent low level pain or
discomfort and chronic severe pain respectively, while the pain
and discomfort associated with Onchoceriasis is place as about
equivalent to our mid-way DW of 0.068. .The DW used for
trichiasis with low vision has varied between different burden
studies. In order to reflect the uncertainty of the contribution of
trichiasis with normal vision to total trachoma burden a range of
DWs for trichiasis with low vision was also used corresponding to
those used in previous studies (Table 3).
Results
Estimating the Years Lived with Disability (YLD)
Incidence rates and duration estimates for each of the trachoma
disease states by age were modelled using DISMOD II and are
presented here in Table 4. Employing these modelled durations
and the disability weights of 0.245 and 0.068 for trichiasis with low
vision and trichiasis with normal vision, respectively, all states of
trachoma combined, incident in 1 year, resulted in 174,550 Years
Lived with Disability in South Sudan (or 16.46 YLD/1000 person
years). Trichiasis with normal vision contributes 19,219 YLDs, or
11%, to the total burden (Figure 1).
Women carry more of the burden than males for all stages of
the disease. The inclusion of trichiasis with normal vision
contributes 11.73% to total burden experienced by females (with
age-weighting) and is equivalent to 30% of the burden amongst
women due to trichiasis with blindness.
Most of the burden associated with trichiasis with normal vision
is experienced during childhood and while the burden of trichiasis
with low vision is placed upon young adults and blindness is mostly
experienced in later life (Figure 2). Age weighting emphasizes the
contribution of trichiasis with normal and low vision on the total
burden of trachoma (Figure 1).
Using alternative assumptions for uncertain estimates
Employing the different disability weights described above in
Table 3, Table 5 reports the resulting range of Years Lived with
Disability (YLD) estimates. Estimates of total YLD were sensitive
to the application of different weights to trichiasis with both
normal and low vision. The difference between the lowest and
highest disability weight for trichiasis with normal vision was 5
times higher and 1.6 times higher for trichiasis with low visions.
Depending on the disability weight employed, the burden due
to trichiasis with normal vision can contribute between 5% and
21% of the total burden of trichiasis adding up to 33, 917 YLD to
the total.
Table 2. Models used to assess the sensitivity of the burden
estimates to uncertainty in the duration.
Name Mean Durations
Trichiasis with NV Model 1a 15 years for ages ,35 and 5 years for ages
.35
Model 2a 25 years for ages ,35 and 15 years for ages
.35
Trichiasis with LV Model 1b 3 years for all age groups
Model 2b 10 years for all age groups
NV – Normal vision.
LV – Low vision.
doi:10.1371/journal.pntd.0001538.t002
Table 3. Disability weights used to assess the sensitivity of
the analysis to uncertainty in severity.
Source Baseline (lower and upper limits)
Blindness 0.6
Low vision 0.245 (0.170–0.282)
Normal vision 0.068 (0.024–0.120)
doi:10.1371/journal.pntd.0001538.t003
Re-Assessing the Burden of Trachoma in South Sudan
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durations of the two disease states. As would be expected, the longer
the duration the more sensitive the results are to the different
disabilityweights.Similarly,becausetrichiasiswithlowvision results
in greater burden in South Sudan than trichiasis with normal vision,
it exhibits more sensitivity to the assumptions employed.
Using the longer duration model 2a can add up to 0.84/1000
person years (or 8,883 YLD) for trichiasis with normal vision as
compared with the short duration model 1a and using model 2b
for trichiasis with low vision can add up to 3.69/1000 person years
(or 39,171 YLD) as compared with the short duration model 1b (in
both cases the highest DW have been applied).
Figure 1. YLDs lost due to trichiasis with different levels of visual impairment in South Sudan. Assessed with (3,1) and without (3,0) age
weighting (disability weights of 0.6, 0.245 and 0.068 for blindness, low vision and normal vision respectively).
doi:10.1371/journal.pntd.0001538.g001
Table 4. Modeled incidence rates (/100) and durations by age for each disease state.
Trichiasis with Blindness Trichiasis with Low Vision Trichiasis with Normal Vision
Males Females Males Females Males Females
Age Incidence Duration Incidence Duration Incidence Duration Incidence Duration Incidence Duration Incidence Duration
0–4’ 0.00 42.10 0.00 44.91 0.01 49.56 0.01 52.76 0.02 53.35 0.04 55.83
‘5–9’ 0.00 41.06 0.00 45.21 0.01 47.74 0.01 50.95 0.07 51.31 0.10 53.77
‘10–14’ 0.00 37.31 0.00 41.02 0.02 43.19 0.03 46.49 0.09 46.97 0.14 49.45
‘15–19’ 0.00 32.66 0.01 36.92 0.05 38.78 0.06 42.11 0.09 42.27 0.14 44.78
‘20–24’ 0.01 29.12 0.01 33.13 0.08 34.73 0.09 38.05 0.10 38.11 0.17 40.61
‘25–29’ 0.02 25.83 0.03 29.86 0.13 31.04 0.16 34.26 0.10 34.27 0.18 36.67
‘30–34’ 0.04 22.96 0.05 26.79 0.23 27.63 0.28 30.68 0.12 30.65 0.21 32.97
‘35–39’ 0.07 20.25 0.10 23.82 0.33 24.39 0.40 27.21 0.10 27.34 0.19 29.55
‘40–44’ 0.13 17.47 0.17 20.78 0.46 21.10 0.54 23.67 0.08 23.94 0.16 26.06
‘45–49’ 0.22 14.79 0.29 17.70 0.59 17.90 0.67 20.17 0.07 20.72 0.13 22.71
‘50–54’ 0.36 12.26 0.45 14.77 0.72 14.85 0.77 16.82 0.05 17.66 0.09 19.49
‘55–59’ 0.61 9.97 0.74 12.06 0.90 12.02 0.90 13.67 0.04 14.85 0.05 16.50
‘60–64’ 1.10 8.00 1.26 9.61 1.22 9.52 1.11 10.79 0.02 12.36 0.02 13.91
‘65–69’ 1.84 6.35 2.04 7.49 1.53 7.32 1.26 8.23 0.01 10.11 0.00 11.19
‘70–74’ 2.95 5.16 3.18 5.93 2.20 5.68 1.69 6.33 0.01 8.15 0.00 8.44
‘75+’ 5.51 2.66 6.70 2.52 3.21 3.56 2.46 3.52 0.07 4.84 0.09 4.20
doi:10.1371/journal.pntd.0001538.t004
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Five attempts to calculate the global burden of trachoma have
been conducted since 1990. The methodologies, parameter
inputs and data sources used in each of these studies have not
always been consistent and are not all directly comparable. The
estimates suffer most from the paucity of reliable data on
trachoma prevalence and incidence and the uncertainty sur-
rounding the estimates used [19]. Furthermore, no data has
previously described the prevalence of trichiasis pre-visual
impairment.
In the present model trichiasis with low vision was the biggest
contributor to the total burden of trachoma which reflects current
knowledge. This work represents the first attempt to estimate the
incidence and burden of trachoma without vision loss in a
population and our analysis reveals that the inclusion of this state
can potentially add a substantial amount to the total trachoma
burden estimates.
Our results also indicated a decreasing incidence of this state
with age in both males and females. Due to the small numbers in
older age groups, however, we have refrained from drawing any
conclusions on this observed trend
As noted elsewhere [10], females carry more of the burden of
trachoma than males. This could partly be due to their longer life
spans and thus a greater number of years spent with visual
impairment. However, the woman’s role in child caring and their
relatively greater exposure to the reservoirs of bacteria carried by
children does put them at greater risk of transmission and they
experience higher rates of incidence for all states through most age
groups. In fact the burden suffered by women, may more likely be
underestimated in this study because we assumed that females had
both an equal risk of mortality due to blindness and low vision as
males as well as equal experiences of severity. Some evidence
suggests, however, that females affected by visual impairment may
experience a higher risk of death to men (3.8 and 1.5 respectively)
[20] and also suffer from greater functional limitation prior to
visual impairment [5].
Duration and disability weights
Valuing health states is a contentious business and disability
weights have attracted a fair amount of critical attention since the
development of the DALY. One of the major challenges in
developing disability weights arises when a disease is characterized
Figure 2. YLDs (3,1) lost due to trichiasis by age in South Sudan.
doi:10.1371/journal.pntd.0001538.g002
Table 5. Years Lived with Disability/1000 person years (3,1) estimated using alternative disability weights.
Total Years Lived with Disability(/1000 p-y)
Disability weights for trichiasis with normal vision
Difference between YLD estimates using
the highest and lowest DW
0.024 0.068 0.120
Trichiasis with Normal Vision 0.64 1.81 3.2 2.56
Disability weights for trichiasis with low vision
0.17 0.245 0.282
Trichiasis with Low Vision 5.46 7.87 9.06 3.6
DW – Disability weight.
doi:10.1371/journal.pntd.0001538.t005
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of differing severity. A series of efforts have attempted to construct
DWs capable of capturing this disability by foregoing the
assumption underlying the standard DALY which requires
independence between duration and disability [21–23]. The
secondary aim of this study was to assess the impact of using
both a range of disability weights and durations. Many of these
assumptions were arbitrary and were not scientifically derived but
they were intended to show the extent to which a range of inputs,
providing a reasonable reflection of the uncertainty around these
parameters, may impact upon the outcome of such an analysis. In
the case of trachoma in South Sudan, the burden estimates are
particularly sensitive to the range of durations employed here.
Conclusions
Regardless of the assumptions used, the health burden of
trachoma is consistently under-estimated because the disease state
of trichiasis without vision loss had not previously been included in
estimations. Including this state increases burden estimates
considerably. Underestimating the disease burden caused by
trachoma understates its importance not only to those directly
affected but also to those at risk. Understating the burden leads to
neglect of disease; not recognizing the impact of successful control
measures and not prioritising trachoma control for neglected
populations.
Burden estimates of a number of diseases classified as ‘neglected
tropical diseases’ have been revisited recently. The burdens
Figure 3. YLDs (3,1) (/1000 person years) using different assumptions about duration and severity in South Sudan.
doi:10.1371/journal.pntd.0001538.g003
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for example have all been re-assessed with the aim of ensuring that
the complex patterns of disability characteristic of these conditions
is taken into account [24–29]. In this study we have looked at a
disease that is characterised by graded severity and noted that the
priority is for more robust estimates of disease duration. Until a
better understanding of trachoma’s natural history is gained,
efforts to perfect the disability weights to be assigned to the
different severity levels will be mostly wasted [23]. Estimating
disease burdens is an iterative process which requires on-going,
self-assessment and self-correction as more data become available.
In the case of trachoma, as with other non-fatal conditions,
there remains considerable uncertainty around the occurrence
parameters, and the duration of different stages of the disease in
particular. Improving these estimates remains a priority.
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